These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 17062254

  • 1. Radioguided detection of lymph node metastasis in non-small cell lung cancer.
    Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T.
    Ann Thorac Surg; 2006 Nov; 82(5):1815-20; discussion 1820. PubMed ID: 17062254
    [Abstract] [Full Text] [Related]

  • 2. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [Abstract] [Full Text] [Related]

  • 3. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J, Milleron B, Vaylet F, Grahek D, Lebeau B, Mangiapan G, Bonardel G, de Labriolle-Vaylet C, Meignan M, Carette MF, Talbot JN, Housset B.
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [Abstract] [Full Text] [Related]

  • 4. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [Abstract] [Full Text] [Related]

  • 5. Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
    Siepel FJ, de Bruin WI, van Duyn EB, Steenvoorde P, Wagenaar NR, Slump CH, van Dalen JA.
    Nucl Med Commun; 2012 Apr; 33(4):439-44. PubMed ID: 22311052
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [Abstract] [Full Text] [Related]

  • 12. Sentinel node and positron emission tomography mapping in lung cancer.
    Nwogu C.
    Semin Thorac Cardiovasc Surg; 2009 Sep; 21(4):323-6. PubMed ID: 20226345
    [Abstract] [Full Text] [Related]

  • 13. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
    Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM.
    J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
    [Abstract] [Full Text] [Related]

  • 14. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A.
    Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
    [Abstract] [Full Text] [Related]

  • 15. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR.
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging.
    Barnett S, Baste JM, Murugappan K, Tog C, Berlangieri S, Scott A, Seevanayagam S, Knight S.
    Eur J Cardiothorac Surg; 2011 Jan; 39(1):96-101. PubMed ID: 20580245
    [Abstract] [Full Text] [Related]

  • 18. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma.
    Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM.
    Ann Thorac Surg; 2003 Sep; 76(3):861-6. PubMed ID: 12963217
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K, Ito K, Hiramatsu Y, Ishikawa T, Sakuma T, Matsunari I, Kuga G, Miura K, Higuchi T, Tonami H, Yamamoto I.
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease.
    An YS, Sun JS, Park KJ, Hwang SC, Park KJ, Sheen SS, Lee S, Lee KB, Yoon JK.
    Lung; 2008 Feb; 186(5):327-36. PubMed ID: 18670805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.